A Consensus Statement for Safety Monitoring Guidelines of Treatments for Major Depressive Disorder
Seetal Dodd, Michael Berk(The Royal Melbourne Hospital), Gin S. Malhi(Royal North Shore Hospital), Steven Moylan(Deakin University), Michael T. Theodoros, Marc Udina(Centro de Investigación Biomédica en Red de Salud Mental), Gordon Parker(UNSW Sydney), Christopher G. Davey(The University of Melbourne), Darryl Bassett(The University of Western Australia), Ian B. Hickie(The University of Sydney), Jon‐Paul Khoo(Toowoomba Hospital), Paul B. Fitzgerald(Australian National University), Bill Lyndon(The University of Sydney), Philip B. Mitchell(UNSW Sydney), Ajeet Singh(Deakin University), John Tiller(The University of Melbourne), Carolyn Doughty(Canterbury District Health Board), Isaac Schweitzer(The University of Melbourne), Francesco Giorlando(The University of Melbourne)
Cited by 45
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
So depression is an inflammatory disease, but where does the inflammation come from?
|BMC Medicine|2013|1.4k
Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group
|Molecular Psychiatry|2016|1.4k
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
|Bipolar Disorders|2012|1.2k
Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group
|Molecular Psychiatry|2015|1.2k